期刊文献+

儿童支原体肺炎49例临床疗效分析

Clinical Effect Analysis of 49 Cases Mycoplasma Pneumonia Children
下载PDF
导出
摘要 目的该文主要统计和分析了关于糖皮质激素在感染MP的儿童中的应用效果以及治疗成本。方法在2018年5月2日至2019年2月1日,抽样选取本院49名感染MP的儿童作为实验研究对象,把以往此类感染的实际治疗手段进行试验和记录,包括症状消退时间的长短对比,血液指标的对比,以及治疗成本的对比。结果在治疗中,按比分成两组,实际治疗组使用针对性的抗生素类药物和糖皮质激素,然后分析患儿的痊愈时间,治疗效果以及经济成本;非实际治疗组在治疗过程中只使用抗生素激素。结论在治疗中尽可能减少糖皮质激素和其他抗生素类药物混合使用,从而既能达到预期的治疗效果,又能节约患者相应的治疗花销。 Objective analyze and count application effect and cost of glucocorticoid in children infected with MP.Methods choose 49 cases MP infected children in our hospital from May 2,2018 to February 1,2019 as experimental objects,test and record actual treatment methods of infection in the past,including comparison of symptom regression time,blood indexes and treatment cost.Results in treatment,divide them into two groups according to ratio.Actual treatment group was treated with targeted antibiotics and glucocorticoids,analyze recovery time,treatment effect and economic cost;non actual treatment group with antibiotic hormones only during treatment process.Conclusion combination of glucocorticoid and other antibiotics should be reduced as much as possible in treatment,can achieve expected treatment effect,and save corresponding treatment cost of patients.
作者 张勇 ZHANG Yong(Weifang City the Second People's Hospital,Weifang,Shandong 261041)
出处 《智慧健康》 2020年第6期138-139,共2页 Smart Healthcare
关键词 真实世界研究 儿童 肺炎支原体感染 临床路径 抗菌药物 糖皮质激素 Real world research Children Mycoplasma pneumoniae infection Clinical pathway Antibiotics Glucocorticoids
  • 相关文献

参考文献4

二级参考文献37

  • 1刘又宁,陈民钧,赵铁梅,王辉,王睿,刘庆锋,蔡柏蔷,曹彬,孙铁英,胡云建,修清玉,周新,丁星,杨岚,卓建生,唐英春,张扣兴,梁德荣,吕晓菊,李胜歧,刘勇,俞云松,魏泽庆,应可净,赵峰,陈萍,侯晓娜.中国城市成人社区获得性肺炎665例病原学多中心调查[J].中华结核和呼吸杂志,2006,29(1):3-8. 被引量:784
  • 2Atkinson TP,Balish MF,Waites KB.Epidemiology,clinicalmanifestations,pathogenesis and laboratory detection of Mycoplasma pneumoniae infection.FEMS Microbiol Rev,2008,32:956-973.
  • 3Arnold FW,Summersgill JT,LaJoie AS,et al.A worldwide perspective of atypical pathogens in community-acquired pneumonia.Am J Respir Crit Care Med,2007,175:1086-1093.
  • 4Ngeow YF,Suwanjutha S,Chantarojanasriri T,et al.An Asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia.Int J Infect Dis,2005,9:144-153.
  • 5Daxboeck F,Krause R,Wenisch C.Laboratory diagnosis of Mycoplasma pneumoniae infection.Clin Microbiol Infect,2003,9:263-273.
  • 6Okazaki N,Narita M,Yamada S,et al.Characteristics of macrolide-resistant Mycoplasma pneumoniae strains isolated from patients and induced with erythromycin in vitro.Microbiol Immunol,2001,45:617-620.
  • 7Morozumi M,Iwata S,Hasegawa K,et al.Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia.Antimicrob Agents Chemother,2008,52:348-350.
  • 8Pereyre S,Charron A,Renaudin H,et al.First report of macrolide-resistant strains and description of a novel nucleotide sequence variation in the P1 adhesin gene in Mycoplasma pneumoniae clinical strains isolated in France over 12 years.J Clin Microbiol,2007,45:3534-3539.
  • 9Dumkel R,von Baum H,Lück PC,et al.Occurrence of macrolide-resistant Mycoplasma pneumoniae strains in Germany.Clin Microbiol Infect,2010,16:613-616.
  • 10Xin D,Mi Z,Han X,et al.Molecular mechanisms of macrolide resistance in clinical isolates of Mycoplasma pneumoniae from China.Antimicrob Agents Chemother,2009,53:2158-2159.

共引文献1301

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部